Personal tools

Coexpression cluster:C203

From FANTOM5_SSTAR

Revision as of 14:19, 21 May 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C203_acute_NK_chronic_CD133_lymphoma_immature_Dendritic



Phase1 CAGE Peaks

Hg19::chr10:1999469..1999478,+p@chr10:1999469..1999478
+
Hg19::chr10:23846022..23846029,+p@chr10:23846022..23846029
+
Hg19::chr10:23846163..23846169,+p@chr10:23846163..23846169
+
Hg19::chr10:23846249..23846267,+p@chr10:23846249..23846267
+
Hg19::chr10:23846319..23846335,+p@chr10:23846319..23846335
+
Hg19::chr10:23858616..23858621,+p@chr10:23858616..23858621
+
Hg19::chr11:126310760..126310781,-p7@KIRREL3
Hg19::chr11:68099033..68099038,-p@chr11:68099033..68099038
-
Hg19::chr12:133240734..133240764,-p@chr12:133240734..133240764
-
Hg19::chr12:4501908..4501927,+p@chr12:4501908..4501927
+
Hg19::chr12:4524557..4524579,+p@chr12:4524557..4524579
+
Hg19::chr12:4524619..4524632,+p@chr12:4524619..4524632
+
Hg19::chr13:100927475..100927483,+p@chr13:100927475..100927483
+
Hg19::chr13:100927491..100927498,+p@chr13:100927491..100927498
+
Hg19::chr13:100927506..100927512,+p@chr13:100927506..100927512
+
Hg19::chr13:49001034..49001075,-p4@LPAR6
Hg19::chr13:49076795..49076798,-p@chr13:49076795..49076798
-
Hg19::chr13:49076880..49076891,-p@chr13:49076880..49076891
-
Hg19::chr13:49077016..49077033,-p@chr13:49077016..49077033
-
Hg19::chr13:49077039..49077054,-p@chr13:49077039..49077054
-
Hg19::chr13:49077093..49077104,-p@chr13:49077093..49077104
-
Hg19::chr13:49077121..49077143,-p@chr13:49077121..49077143
-
Hg19::chr14:77248056..77248105,-p1@ENST00000556368
Hg19::chr14:93551934..93551950,-p@chr14:93551934..93551950
-
Hg19::chr15:29745140..29745158,-p2@FAM189A1
Hg19::chr15:49907736..49907748,+p@chr15:49907736..49907748
+
Hg19::chr15:94987207..94987211,-p@chr15:94987207..94987211
-
Hg19::chr15:95120128..95120140,-p@chr15:95120128..95120140
-
Hg19::chr15:95120151..95120158,-p@chr15:95120151..95120158
-
Hg19::chr16:4714466..4714476,+p9@MGRN1
Hg19::chr16:87812662..87812682,-p@chr16:87812662..87812682
-
Hg19::chr16:89168889..89168898,+p10@ACSF3
Hg19::chr18:45498690..45498695,-p@chr18:45498690..45498695
-
Hg19::chr18:45546950..45546957,-p@chr18:45546950..45546957
-
Hg19::chr18:45546969..45546979,-p@chr18:45546969..45546979
-
Hg19::chr18:66451511..66451519,-p@chr18:66451511..66451519
-
Hg19::chr18:66451542..66451549,-p@chr18:66451542..66451549
-
Hg19::chr18:73353417..73353422,+p@chr18:73353417..73353422
+
Hg19::chr19:16228733..16228742,+p@chr19:16228733..16228742
+
Hg19::chr19:1842983..1842999,-p@chr19:1842983..1842999
-
Hg19::chr19:47226533..47226549,-p@chr19:47226533..47226549
-
Hg19::chr1:10434688..10434703,+p@chr1:10434688..10434703
+
Hg19::chr1:198985286..198985295,+p2@ENST00000432488
Hg19::chr1:198985298..198985308,+p1@ENST00000432488
Hg19::chr1:198985325..198985330,+p3@ENST00000432488
Hg19::chr1:222273765..222273768,+p@chr1:222273765..222273768
+
Hg19::chr1:3536212..3536225,+p@chr1:3536212..3536225
+
Hg19::chr20:60705265..60705277,+p@chr20:60705265..60705277
+
Hg19::chr21:16811526..16811529,-p@chr21:16811526..16811529
-
Hg19::chr21:43542270..43542279,+p@chr21:43542270..43542279
+
Hg19::chr21:43543479..43543483,-p@chr21:43543479..43543483
-
Hg19::chr22:22294029..22294045,-p@chr22:22294029..22294045
-
Hg19::chr2:129248071..129248083,-p@chr2:129248071..129248083
-
Hg19::chr2:16618404..16618417,-p@chr2:16618404..16618417
-
Hg19::chr2:16618675..16618679,-p@chr2:16618675..16618679
-
Hg19::chr2:1997573..1997576,+p@chr2:1997573..1997576
+
Hg19::chr2:54643949..54643962,+p@chr2:54643949..54643962
+
Hg19::chr2:54649524..54649529,-p@chr2:54649524..54649529
-
Hg19::chr2:58941579..58941613,+p@chr2:58941579..58941613
+
Hg19::chr2:58942626..58942633,+p@chr2:58942626..58942633
+
Hg19::chr2:58942673..58942680,+p@chr2:58942673..58942680
+
Hg19::chr2:58942707..58942719,+p@chr2:58942707..58942719
+
Hg19::chr3:124390180..124390188,+p@chr3:124390180..124390188
+
Hg19::chr3:194968576..194968594,-p3@XXYLT1
Hg19::chr4:117194661..117194666,-p@chr4:117194661..117194666
-
Hg19::chr4:117248477..117248490,-p@chr4:117248477..117248490
-
Hg19::chr4:2916272..2916283,+p38@ADD1
Hg19::chr4:55685387..55685409,+p@chr4:55685387..55685409
+
Hg19::chr5:83260127..83260138,-p@chr5:83260127..83260138
-
Hg19::chr6:109702885..109702908,-p5@CD164
Hg19::chr6:135536715..135536763,-p@chr6:135536715..135536763
-
Hg19::chr6:20565177..20565196,-p@chr6:20565177..20565196
-
Hg19::chr6:2750288..2750300,-p@chr6:2750288..2750300
-
Hg19::chr6:33399093..33399111,+p5@SYNGAP1
Hg19::chr6:6587290..6587314,+p@chr6:6587290..6587314
+
Hg19::chr6:6588295..6588313,+p4@LY86
Hg19::chr6:6588316..6588329,+p3@LY86
Hg19::chr6:74438849..74438886,+p@chr6:74438849..74438886
+
Hg19::chr7:100884779..100884815,-p7@FIS1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0000266mitochondrial fission0.0392591767343367
GO:0031307integral to mitochondrial outer membrane0.0392591767343367
GO:0031306intrinsic to mitochondrial outer membrane0.0392591767343367
GO:0016559peroxisome fission0.0392591767343367
GO:0032592integral to mitochondrial membrane0.0392591767343367
GO:0048285organelle fission0.0436123201495787
GO:0007157heterophilic cell adhesion0.0475378821576717
GO:0000209protein polyubiquitination0.0475378821576717
GO:0002376immune system process0.0475378821576717
GO:0005779integral to peroxisomal membrane0.0475378821576717
GO:0031231intrinsic to peroxisomal membrane0.0475378821576717



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell2.27e-47172
angioblastic mesenchymal cell2.27e-47172
hematopoietic cell9.28e-46182
hematopoietic oligopotent progenitor cell2.74e-44165
hematopoietic multipotent progenitor cell2.74e-44165
myeloid cell7.88e-37112
common myeloid progenitor7.88e-37112
leukocyte5.82e-35140
hematopoietic lineage restricted progenitor cell1.34e-28124
nongranular leukocyte9.37e-27119
granulocyte monocyte progenitor cell9.06e-2471
myeloid leukocyte2.18e-2376
myeloid lineage restricted progenitor cell6.55e-2170
macrophage dendritic cell progenitor7.81e-2165
monopoietic cell1.20e-1963
monocyte1.20e-1963
monoblast1.20e-1963
promonocyte1.20e-1963
CD14-positive, CD16-negative classical monocyte2.13e-1642
classical monocyte6.81e-1645
lymphocyte1.40e-0753
common lymphoid progenitor1.40e-0753
lymphoid lineage restricted progenitor cell1.54e-0752
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.93e-25102
blood island1.93e-25102
hemolymphoid system2.69e-25112
bone marrow3.37e-1980
immune system7.70e-19115
bone element1.57e-1786
adult organism8.11e-12115
skeletal element1.89e-11101
skeletal system1.89e-11101
Disease
Ontology termp-valuen
hematologic cancer2.37e-1851
immune system cancer2.37e-1851
leukemia4.18e-1639
myeloid leukemia1.04e-1231


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.